CRT 23 Late-Breaking Science Video Collection
Published: 17 March 2023
6m 1sPart 1 | Session 4 IVUS Vs QCA-Guided PCI for Coronary Artery Stenosis: The OPTIMAL Trial
4m 19sPart 1 | Session 1 PCI Vs CABG in Left Main Coronary Artery Disease With or Without Diabetes: A Pooled Analysis Prakriti Gaba
For short, concise coverage of the key data released at CRT 2023, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
More from this programme
About the episode
CRT 23 - In this short interview from CRT's 2023 Scientific Sessions, we are joined by Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, NL) to outline the FAST III Trial, sponsored by the European Cardiovascular Research Institute. In this study, over 2000 patients were randomized in a 1:1 manner, to vFFR or FFR guided revascularization for the treatment of coronary artery disease. Patients are followed up to 12 months, at which point, the primary endpoints of all-cause death, myocardial infarction and revascularization are analysed.
- What was the rationale behind this study?
- What was the patient population, current enrollment status and study design?
- What is the potential impact of the results of this trial?
- What are the next steps for FAST III?
Recorded remotely from Rotterdam, 2023.
Editor: Jordan Rance
Videography: Dan Brent
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Joost is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Joost is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.